BR0010914A - Composto medicamento agente profilático ou terapêutico, e, uso do composto - Google Patents

Composto medicamento agente profilático ou terapêutico, e, uso do composto

Info

Publication number
BR0010914A
BR0010914A BR0010914-2A BR0010914A BR0010914A BR 0010914 A BR0010914 A BR 0010914A BR 0010914 A BR0010914 A BR 0010914A BR 0010914 A BR0010914 A BR 0010914A
Authority
BR
Brazil
Prior art keywords
compound
therapeutic agent
prophylactic
medicine prophylactic
medicine
Prior art date
Application number
BR0010914-2A
Other languages
English (en)
Inventor
Takashi Fujita
Toshihiko Fujiwara
Takashi Izumi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15340495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010914(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR0010914A publication Critical patent/BR0010914A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"COMPOSTO MEDICAMENTO AGENTE PROFILáTICO OU TERAPêUTICO, E, USO DO COMPOSTO". A presente invenção diz respeito ao cloridreto do composto 5-[4-(6-metóxi- 1 -metil- 1 H-benzimidazol-2-ilmetóxi)benzil]tiazolidin-2,4-diona da seguinte estrutura (I) que apresenta uma excelente atividade hipoglicêmica e outras.
BR0010914-2A 1999-05-24 2000-05-24 Composto medicamento agente profilático ou terapêutico, e, uso do composto BR0010914A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14351399 1999-05-24
PCT/JP2000/003325 WO2000071540A1 (fr) 1999-05-24 2000-05-24 Chlorhydrate de compose heterocyclique fusionne

Publications (1)

Publication Number Publication Date
BR0010914A true BR0010914A (pt) 2002-02-19

Family

ID=15340495

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010914-2A BR0010914A (pt) 1999-05-24 2000-05-24 Composto medicamento agente profilático ou terapêutico, e, uso do composto

Country Status (25)

Country Link
US (1) US6706746B2 (pt)
EP (1) EP1180519B1 (pt)
KR (2) KR100783348B1 (pt)
CN (1) CN1156473C (pt)
AT (1) ATE294799T1 (pt)
AU (1) AU763731B2 (pt)
BR (1) BR0010914A (pt)
CA (1) CA2375017C (pt)
CZ (1) CZ297927B6 (pt)
DE (1) DE60019919T2 (pt)
DK (1) DK1180519T3 (pt)
ES (1) ES2240099T3 (pt)
HK (1) HK1042087B (pt)
HU (1) HU229340B1 (pt)
IL (1) IL146568A0 (pt)
MX (1) MXPA01012044A (pt)
NO (1) NO321578B1 (pt)
NZ (1) NZ515570A (pt)
PL (1) PL209389B1 (pt)
PT (1) PT1180519E (pt)
RU (1) RU2214410C2 (pt)
TR (1) TR200103353T2 (pt)
TW (1) TWI284533B (pt)
WO (1) WO2000071540A1 (pt)
ZA (1) ZA200109576B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
WO2002051441A1 (fr) 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
US6756399B2 (en) * 2001-06-29 2004-06-29 The United States Of America As Represented By The Department Of Health And Human Services Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
WO2003082865A1 (fr) * 2002-04-01 2003-10-09 Sankyo Company, Limited Composition médicinale antitumorale
AU2003254795A1 (en) * 2002-08-02 2004-02-23 Sankyo Company, Limited Resorcinol derivative
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7718377B2 (en) 2003-05-29 2010-05-18 Kyoto Pharmaceutical Industries, Ltd. Insulin resistance curative and method of screening the same
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
CA2543452C (en) * 2003-10-24 2012-03-13 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
EP1566202A1 (en) * 2004-02-23 2005-08-24 Sahltech I Göteborg AB Use of resistin antagonists in the treatment of rheumatoid arthritis
EP1731170A1 (en) * 2004-03-29 2006-12-13 Sankyo Company, Limited Therapeutic agent for diabetes containing insulin resistance improving agent
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
KR20070086007A (ko) * 2004-12-13 2007-08-27 다이이찌 산쿄 가부시키가이샤 당뇨병의 치료를 위한 의약 조성물
KR20070086137A (ko) * 2004-12-15 2007-08-27 다이이찌 산쿄 가부시키가이샤 ＦＢＰａｓｅ 저해제를 함유하는 의약 조성물
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
EP1889618A4 (en) * 2005-05-27 2010-11-24 Daiichi Sankyo Co Ltd COMBINED MEDICINE FOR THE TREATMENT OF DIABETES
US20080262054A1 (en) * 2005-07-08 2008-10-23 Takao Kawasaki Pharmaceutical Composition Containing Thiazolidinedione Compound
TW200738266A (en) * 2005-09-29 2007-10-16 Sankyo Co Pharmaceutical agent containing insulin resistance improving agent
US8148389B2 (en) 2005-11-28 2012-04-03 Senju Pharmaceutical Co., Ltd. Pharmaceutical comprising PPAR agonist
MX2009010790A (es) * 2007-04-05 2009-10-29 Daiichi Sankyo Co Ltd Derivados de heteroarilo biciclico fusionados.
EP2151438B1 (en) 2007-05-21 2012-10-31 Senju Pharmaceutical Co., Ltd. Pharmaceutical containing ppar-delta agonist
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
RU2480463C1 (ru) 2009-03-05 2013-04-27 Дайити Санкио Компани, Лимитед Пиридилокси производные, полезные в качестве активатора/модулятора гамма-рецептора, активируемого пролифератором пероксисом (ppar) гамма
US8969581B2 (en) 2013-03-14 2015-03-03 Deuterx, Llc 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118474A (en) 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5798375A (en) 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
TR200200111T2 (tr) * 1999-07-19 2002-08-21 Sankyo Company Limited Neoplazmalar için terapötik ve profilaktik maddeler

Also Published As

Publication number Publication date
ATE294799T1 (de) 2005-05-15
HUP0201334A2 (en) 2002-10-28
CZ297927B6 (cs) 2007-05-02
HK1042087B (zh) 2005-09-09
KR100783348B1 (ko) 2007-12-07
RU2214410C2 (ru) 2003-10-20
KR20010113972A (ko) 2001-12-28
US20020111373A1 (en) 2002-08-15
PL209389B1 (pl) 2011-08-31
MXPA01012044A (es) 2002-05-06
IL146568A0 (en) 2002-07-25
HK1042087A1 (en) 2002-08-02
HU229340B1 (en) 2013-11-28
PL351650A1 (en) 2003-05-19
DE60019919D1 (de) 2005-06-09
AU763731B2 (en) 2003-07-31
CN1364168A (zh) 2002-08-14
HUP0201334A3 (en) 2002-11-28
PT1180519E (pt) 2005-06-30
EP1180519A4 (en) 2002-07-10
ZA200109576B (en) 2003-02-20
AU4948700A (en) 2000-12-12
KR20070034112A (ko) 2007-03-27
CA2375017C (en) 2009-05-19
CA2375017A1 (en) 2000-11-30
KR100748053B1 (ko) 2007-08-09
EP1180519A1 (en) 2002-02-20
NO20015712L (no) 2001-12-20
CZ20014182A3 (cs) 2002-04-17
NZ515570A (en) 2003-11-28
TR200103353T2 (tr) 2002-04-22
EP1180519B1 (en) 2005-05-04
ES2240099T3 (es) 2005-10-16
WO2000071540A1 (fr) 2000-11-30
TWI284533B (en) 2007-08-01
NO321578B1 (no) 2006-06-06
DE60019919T2 (de) 2006-02-16
US6706746B2 (en) 2004-03-16
DK1180519T3 (da) 2005-06-13
NO20015712D0 (no) 2001-11-23
CN1156473C (zh) 2004-07-07

Similar Documents

Publication Publication Date Title
BR0010914A (pt) Composto medicamento agente profilático ou terapêutico, e, uso do composto
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
DE60138948D1 (de) Medizinische aerosolformulierung von antidiabetika
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
SE0001899D0 (sv) New compounds
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
WO2001066564A3 (en) Gamma-secretase inhibitors
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
DE60022756D1 (de) Hautpflegezusammensetzung
NO952309D0 (no) Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
BR9809968A (pt) Aplicação de derivados tiazolidinadiona no tratamento da pcos e diabetes gestacional
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
KR950703953A (ko) 2-아미노-6-n-프로필아미노-4, 5, 6, 7-테트라하이드로벤조티아졸(프라미펙솔)의 항우울제로서의 용도(Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol)as an antidepressant drug)
DK261490D0 (da) New pharmaceutical compound
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
BR0309256A (pt) Sistemas de liberação responsivos à temperatura
BR0013353A (pt) Combinação de substância ativa com clonidina
BR0114196A (pt) Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
FR2836336B1 (fr) Utilisation dans un traitement cosmetique d'une fraction phenolique riche en dihydrochalcones
DE60128100D1 (de) Analgetisches arzneimittel
NO20012310D0 (no) Optisk aktiv pyridyl-4H-1,2,4-oksazdiazinderivat og dets anvendelse ved behandling av karsykdommer
NZ516620A (en) 1,4-substituted 4,4-diaryl cyclohexanes
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]